tm
Seeing Is Believing
tm
Seeing Is Believing
RVPH is currently covered by 5 analysts
Reviva Pharmaceuticals Holdings's activity chart (see below) currently has 14 price targets and 35 ratings on display. The stock rating distribution of RVPH is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 64.8 days.
Highest price target for RVPH is $1, Lowest price target is $1.
Most recent stock forecast was given by JASON KOLBERT from D. BORAL CAPITAL on 05-Mar-2026. First documented stock forecast 26-Jul-2021.
Currently out of the existing stock ratings of RVPH, 15 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Jan-2023
Buy Since 10-Jan-2025
$2
$-0.47 (-19.03%)
Buy Since 20-Sep-2023
$12
$9.53 (385.83%)
$12
What is RVPH (Reviva Pharmaceuticals Holdings) average time for price targets to be met?
Which analyst has the current highest performing score on RVPH (Reviva Pharmaceuticals Holdings) with a proven track record?
Which analyst has the current lower performing score on RVPH (Reviva Pharmaceuticals Holdings) with a proven track record?
Which analyst has the most public recommendations on RVPH (Reviva Pharmaceuticals Holdings)?
Which analyst is the currently most bullish on RVPH (Reviva Pharmaceuticals Holdings)?
Which analyst is the currently most reserved on RVPH (Reviva Pharmaceuticals Holdings)?
